DZ2521A1 - Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement. - Google Patents
Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement.Info
- Publication number
- DZ2521A1 DZ2521A1 DZ980131A DZ980131A DZ2521A1 DZ 2521 A1 DZ2521 A1 DZ 2521A1 DZ 980131 A DZ980131 A DZ 980131A DZ 980131 A DZ980131 A DZ 980131A DZ 2521 A1 DZ2521 A1 DZ 2521A1
- Authority
- DZ
- Algeria
- Prior art keywords
- ethoxyübenzylü
- thiazolidine
- dione
- pyridyl
- insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712866.4A GB9712866D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ2521A1 true DZ2521A1 (fr) | 2003-02-08 |
Family
ID=10814527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ980131A DZ2521A1 (fr) | 1997-06-18 | 1998-06-17 | Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement. |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0999837A1 (xx) |
JP (1) | JP2002504138A (xx) |
KR (1) | KR20010013843A (xx) |
CN (1) | CN1133431C (xx) |
AP (1) | AP1287A (xx) |
AR (2) | AR015894A1 (xx) |
AU (1) | AU8216398A (xx) |
BG (1) | BG104059A (xx) |
BR (1) | BR9810444A (xx) |
CA (1) | CA2294141A1 (xx) |
CO (1) | CO4940454A1 (xx) |
DZ (1) | DZ2521A1 (xx) |
EA (1) | EA004800B1 (xx) |
GB (1) | GB9712866D0 (xx) |
HU (1) | HUP0003260A3 (xx) |
ID (1) | ID23951A (xx) |
IL (1) | IL133143A0 (xx) |
IN (1) | IN189723B (xx) |
MA (1) | MA26511A1 (xx) |
NO (1) | NO996265D0 (xx) |
OA (1) | OA11517A (xx) |
PE (1) | PE104499A1 (xx) |
PL (1) | PL343123A1 (xx) |
SK (1) | SK179399A3 (xx) |
TR (1) | TR199903095T2 (xx) |
TW (1) | TW587937B (xx) |
UA (1) | UA70299C2 (xx) |
UY (1) | UY25050A1 (xx) |
WO (1) | WO1998057636A1 (xx) |
ZA (1) | ZA985237B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291495B1 (en) * | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
TWI249401B (en) | 1999-04-14 | 2006-02-21 | Takeda Chemical Industries Ltd | Agent for improving ketosis |
BR0009934A (pt) | 1999-04-23 | 2002-06-04 | Smithkline Beecham Plc | Produto farmacêutico |
EP1849475A1 (en) * | 1999-06-21 | 2007-10-31 | Eli Lilly & Company | Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes |
WO2001000223A2 (en) * | 1999-06-25 | 2001-01-04 | Minimed Inc. | Multiple agent diabetes therapy |
US6468507B1 (en) * | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
GB0023970D0 (en) * | 2000-09-29 | 2000-11-15 | Smithkline Beecham Plc | Novel pharmaceutical |
WO2002067969A2 (en) | 2001-02-21 | 2002-09-06 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
US6531461B1 (en) | 2001-06-04 | 2003-03-11 | Louis Obyo Obyo Nelson | Medicament for the treatment of diabetes |
US20020198203A1 (en) * | 2001-06-07 | 2002-12-26 | Wyeth | Combination of a PTPase inhibitor and a thiazolidinedione agent |
US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
DE60317365T2 (de) | 2002-11-08 | 2008-08-21 | F. Hoffmann-La Roche Ag | Substituierte 4-alkoxyoxazol derivate als ppar agonisten |
US7264813B2 (en) * | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
CN102389427A (zh) * | 2011-10-10 | 2012-03-28 | 成都恒瑞制药有限公司 | 含有罗格列酮和盐酸西替利嗪的固体口服制剂 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE376829T1 (de) * | 1993-09-15 | 2007-11-15 | Daiichi Sankyo Co Ltd | Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm) |
WO1997005875A2 (en) * | 1995-08-10 | 1997-02-20 | Warner-Lambert Company | A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
KR19990045756A (ko) * | 1995-09-18 | 1999-06-25 | 윌리암 엘. 레스페스 | Rxr 작용제를 이용하는 niddm 치료 방법 |
-
1997
- 1997-06-18 GB GBGB9712866.4A patent/GB9712866D0/en active Pending
-
1998
- 1998-06-15 PL PL98343123A patent/PL343123A1/xx unknown
- 1998-06-15 KR KR1019997011864A patent/KR20010013843A/ko not_active Application Discontinuation
- 1998-06-15 IL IL13314398A patent/IL133143A0/xx unknown
- 1998-06-15 AU AU82163/98A patent/AU8216398A/en not_active Abandoned
- 1998-06-15 WO PCT/EP1998/003692 patent/WO1998057636A1/en not_active Application Discontinuation
- 1998-06-15 EA EA200000042A patent/EA004800B1/ru not_active IP Right Cessation
- 1998-06-15 HU HU0003260A patent/HUP0003260A3/hu unknown
- 1998-06-15 EP EP98932169A patent/EP0999837A1/en not_active Withdrawn
- 1998-06-15 ID IDW991627A patent/ID23951A/id unknown
- 1998-06-15 CN CNB988062232A patent/CN1133431C/zh not_active Expired - Fee Related
- 1998-06-15 BR BR9810444-6A patent/BR9810444A/pt not_active IP Right Cessation
- 1998-06-15 AP APAP/P/1999/001718A patent/AP1287A/en active
- 1998-06-15 UA UA99126881A patent/UA70299C2/uk unknown
- 1998-06-15 CA CA002294141A patent/CA2294141A1/en not_active Abandoned
- 1998-06-15 TR TR1999/03095T patent/TR199903095T2/xx unknown
- 1998-06-15 SK SK1793-99A patent/SK179399A3/sk unknown
- 1998-06-15 JP JP50375799A patent/JP2002504138A/ja not_active Ceased
- 1998-06-17 AR ARP980102886A patent/AR015894A1/es not_active Application Discontinuation
- 1998-06-17 AR ARP980102883A patent/AR012997A1/es not_active Application Discontinuation
- 1998-06-17 DZ DZ980131A patent/DZ2521A1/xx active
- 1998-06-17 TW TW087109619A patent/TW587937B/zh not_active IP Right Cessation
- 1998-06-17 MA MA25122A patent/MA26511A1/fr unknown
- 1998-06-17 ZA ZA9805237A patent/ZA985237B/xx unknown
- 1998-06-18 CO CO98034654A patent/CO4940454A1/es unknown
- 1998-06-18 IN IN1698DE1998 patent/IN189723B/en unknown
- 1998-06-18 PE PE1998000535A patent/PE104499A1/es not_active Application Discontinuation
- 1998-06-18 UY UY25050A patent/UY25050A1/es unknown
-
1999
- 1999-12-17 OA OA9900296A patent/OA11517A/en unknown
- 1999-12-17 NO NO996265A patent/NO996265D0/no not_active Application Discontinuation
-
2000
- 2000-01-06 BG BG104059A patent/BG104059A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1133431C (zh) | 2004-01-07 |
TW587937B (en) | 2004-05-21 |
AR015894A1 (es) | 2001-05-30 |
KR20010013843A (ko) | 2001-02-26 |
IN189723B (xx) | 2003-04-19 |
EP0999837A1 (en) | 2000-05-17 |
JP2002504138A (ja) | 2002-02-05 |
NO996265L (no) | 1999-12-17 |
WO1998057636A1 (en) | 1998-12-23 |
SK179399A3 (en) | 2000-11-07 |
BG104059A (en) | 2000-10-31 |
HUP0003260A2 (hu) | 2001-05-28 |
ZA985237B (en) | 2000-02-17 |
UY25050A1 (es) | 2000-09-29 |
AU8216398A (en) | 1999-01-04 |
HUP0003260A3 (en) | 2001-12-28 |
TR199903095T2 (xx) | 2000-08-21 |
PL343123A1 (en) | 2001-07-30 |
PE104499A1 (es) | 2000-01-13 |
AR012997A1 (es) | 2000-11-22 |
EA004800B1 (ru) | 2004-08-26 |
ID23951A (id) | 2000-06-08 |
AP9901718A0 (en) | 1999-12-31 |
AP1287A (en) | 2004-06-26 |
OA11517A (en) | 2004-02-04 |
EA200000042A1 (ru) | 2000-08-28 |
CO4940454A1 (es) | 2000-07-24 |
NO996265D0 (no) | 1999-12-17 |
BR9810444A (pt) | 2000-09-05 |
UA70299C2 (en) | 2004-10-15 |
MA26511A1 (fr) | 2004-12-20 |
CN1260715A (zh) | 2000-07-19 |
GB9712866D0 (en) | 1997-08-20 |
IL133143A0 (en) | 2001-03-19 |
CA2294141A1 (en) | 1998-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2521A1 (fr) | Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement. | |
RU2159761C2 (ru) | Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения | |
DZ2420A1 (fr) | Formulations nouvelles comprenant l'amoxycilline et du clavulanate et procédé pour leur préparation. | |
DZ2753A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant. | |
DZ2581A1 (fr) | Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant. | |
DE69821132D1 (de) | 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes | |
NL300057I2 (nl) | Farmacologisch actieve 1,5-diaryl-3-gesubstitueerde-pyrazolen en werkwijze voor het synthetiseren e rvan. | |
GEP20032995B (en) | 1-Amino-Alkylcyclohexane NMDA Receptor Antagonists | |
MA26420A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation. | |
DZ2221A1 (fr) | Trihydrate de mésylate de 5-(2-(4-(1,2-benzisothiazole-3-yi)-1-pipérazinyl)-éthyl)-6-chloro-1,3-dihydro-2h-indole-2-one, procédé pour sa préparation et compositions pharmaceutiques le contenant. | |
FR2732223B1 (fr) | Composition pharmaceutique pour administration transdermique | |
MA26508A1 (fr) | Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation. | |
NL300258I1 (nl) | Farmaceutische samenstelling voor toepassing in debehandeling van diabetes. | |
MA26516A1 (fr) | Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant. | |
NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
DZ2539A1 (fr) | Compositions pharmaceutiques pour le traitement dela résistance à l'insuline. | |
DZ2414A1 (fr) | 2-amino-6-(2-substitué-4-phenoxy)substituté-pyridines procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
ATE228360T1 (de) | Stabilisierte schilddrüsenhormonhaltige arzneimittel | |
DZ2600A1 (fr) | Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation. | |
DZ2550A1 (fr) | Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
FR2716075B1 (fr) | Procédé pour renforcer l'efficacité d'un produit chimique agricole, renforçateur et composition de renforçateur utilisés dans ce procédé et composition chimique agricole comprenant ce renforçateur. | |
MA26487A1 (fr) | Heterocyclecetohydrazides inhibiteurs de proteases, procede pour leur preparation et compositions pharmaceutiques les contenant . | |
ATE221391T1 (de) | Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln | |
DZ2510A1 (fr) | Composition comprenant de la 5-Ä4-Ä2-(n-méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜthiazolidine-2,4-dione et procédé pour sa préparation. |